Paper Details

  1. Home
  2. Paper Details

Pulmonary hypertension inhaled therapies: An updated review.

Author: El-KershKarim, JalilBilal A

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
ReviewAn article that critically examines existing research on a particular topic and summarizes the current state of knowledge in the field.

Overview

This review article summarizes the evidence for the currently approved inhaled PAH/PH therapies, discusses the available inhalation devices, presents a roadmap for successful treatment strategy, and presents several inhaled PAH/PH therapies in the pipeline.
Paper Details　
Original Abstract of the Article :
Treatments of pulmonary hypertension (PH) continue to evolve with approval of new therapies. The currently FDA approved inhaled PH therapies include inhaled iloprost for group 1 pulmonary arterial hypertension (PAH), inhaled treprostinil solution and treprostinil dry powder inhaler for both group 1 ...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1016/j.amjms.2023.03.002

データ提供：米国国立医学図書館（NLM）

Inhaled Therapies for Pulmonary Hypertension: A Breath of Fresh Air

The field of [pulmonary hypertension (PH)] treatment is a hot topic in [cardiology]. This research offers a comprehensive review of [inhaled therapies] for [pulmonary hypertension]. The authors explore the latest [FDA-approved] inhaled therapies, including [inhaled iloprost], [inhaled treprostinil solution], and [inhaled treprostinil dry powder inhaler]. They delve into the [clinical trials] that led to these approvals, including [INCREASE trial] and [BREEZE study]. The review also examines the potential of [inhaled PH therapies] currently under development. This research provides a valuable roadmap for clinicians seeking to treat [pulmonary hypertension] with the most effective therapies.

Inhaled Therapies for Pulmonary Hypertension: A Breath of Hope

The use of [inhaled therapies] shows exciting potential in treating [pulmonary hypertension]. These therapies offer a more targeted approach, potentially reducing [systemic side effects] by delivering the medication directly to the [lungs]. The future of [pulmonary hypertension] treatment appears bright, with [several promising molecules] in the pipeline.

Breathing Easy: Inhaled Therapies for Pulmonary Hypertension

This study is a welcome breath of fresh air for individuals with [pulmonary hypertension]. It provides a comprehensive overview of current and future therapies, offering hope for improved treatment options. It's important to remember that [pulmonary hypertension] is a complex condition and each patient's treatment plan should be individualized. If you have any concerns about [pulmonary hypertension], it's best to discuss them with your doctor.

Dr. Camel's Conclusion

This review sheds light on the exciting progress in inhaled therapies for pulmonary hypertension. These advancements offer a new way to treat this complex condition, bringing hope for a better quality of life for individuals with PH. As a researcher, I am hopeful that future research will continue to refine and enhance these therapies, leading to even better outcomes for patients.

Date :
  1. Date Completed 2023-06-12
  2. Date Revised 2023-11-16
Further Info :

Pubmed ID

36921672

DOI: Digital Object Identifier

10.1016/j.amjms.2023.03.002

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.